Healthcare Services

The Nephrotic Syndrome Market Is Advancing With Support From Rising Incidence Of Kidney Diseases Driving Growth In The Market

June 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Will Be The Estimated Market Size Of The Nephrotic Syndrome Market By 2030?

The market for nephrotic syndrome has experienced substantial growth in recent times. Its valuation is projected to increase from $0.96 billion in 2025 to $1.06 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.6%. Historically, this expansion has been driven by the elevated prevalence of diabetes and hypertension, the dependence on steroids for therapy, insufficient diagnostic understanding, the progressive integration of dialysis technologies, and an uptick in childhood nephrotic syndrome cases.

The nephrotic syndrome market size is poised for substantial expansion in the coming years. It is expected to attain $1.58 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.4%. This growth during the forecast period is attributed to advancements in targeted therapies, an increasing application of precision nephrology, the development of enhanced dialysis devices, a rise in investment in kidney replacement therapy innovations, and the growing adoption of molecular diagnostic tools. Major developments anticipated in the forecast period include a surging use of immunosuppressive therapies, increasing demand for advanced dialysis and kidney support devices, a greater uptake of early diagnostic screening programs, the higher prevalence of chronic kidney diseases driving treatment needs, and the expansion of personalized medicine approaches in nephrology.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21228&type=smp

Which Drivers Are Advancing The Nephrotic Syndrome Market Growth?

A growing number of kidney disease cases is anticipated to drive forward the nephrotic syndrome market. Kidney diseases describe conditions or disorders that impair the function of the kidneys, which are essential organs responsible for filtering waste and excess fluids from the blood. The rising frequency of kidney diseases is linked to factors such as diabetes, hypertension, obesity, an aging population, and changes in lifestyle, including high sodium intake and insufficient hydration. Nephrotic syndrome contributes to kidney diseases by damaging the glomeruli, thus hindering the kidney’s capacity to filter waste and retain crucial proteins. For example, in June 2023, data from Oxford Academic, an academic research platform of UK-based Oxford University Press, projected that the prevalence of CKD in the UK would rise by 4% from 8.27 million to 8.61 million people between 2022 and 2032. The expected stage distribution in 2032 is 30.36% for stage 1, 21.07% for stage 2, 29.78% for stage 3a, 11.86% for stage 3b, 4.15% for stage 4, and 2.78% for stage 5. As a result, the increasing incidence of kidney diseases is propelling the growth of the nephrotic syndrome market.

What Are The Major Segment Categories Within The Nephrotic Syndrome Market?

The nephrotic syndrome market covered in this report is segmented –

1) By Type: Drugs, Devices

2) By Diagnosis Tests: Urinalysis, Glomerular Filtration Rate (GFR), Blood Test, Kidney Biopsy, Computerized Tomography (CT) Scan

3) By Application: Clinics, Hospitals, Specialty Centres, Other Applications

Subsegments:

1) By Drugs: Steroids, Immunosuppressants, Diuretics, ACE Inhibitors

2) By Devices: Dialysis Machines, Peritoneal Dialysis Catheters, Hemodialysis Catheters, Kidney Replacement Therapy Devices

What Trends Are Shaping The Nephrotic Syndrome Market Structure?

Leading companies in the neonatal respiratory distress syndrome treatment market are concentrating on developing advanced solutions, such as next-generation, portable nitric-oxide delivery systems. These efforts aim to enhance oxygenation, reduce treatment complications, and broaden access beyond traditional NICU settings. Portable nitric-oxide systems are medical devices designed to generate and deliver inhaled nitric oxide on demand, thereby improving oxygenation and alleviating pulmonary hypertension in neonates with hypoxic respiratory failure, while also allowing safe use during patient transport. For instance, in June 2025, Beyond Air Inc., a US-based medical device company, submitted a PMA supplement to the U.S. Food and Drug Administration for LungFit PH 2, which is a lighter and transport-ready nitric oxide generator that utilizes the company’s patented Ionizer technology. This device, engineered for enhanced portability and convenience, ensures continuous nitric oxide delivery while minimizing nitrogen dioxide production, thereby guaranteeing safer therapy even during neonatal transport. Concurrently, phase-4 registry data for INOmax, a well-established iNO therapy by Mallinckrodt, continues to demonstrate real-world benefits in neonates with pulmonary hypertension, underscoring the clinical importance of inhaled nitric oxide in managing hypoxic respiratory failure in newborns.

Which Key Players Are Active In The Nephrotic Syndrome Market?

Major companies operating in the nephrotic syndrome market are Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Amgen Inc., Eli Lilly and Company, Asahi Kasei Corporation, Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Vertex Pharmaceuticals, Chugai Pharmaceutical Co. Ltd., Mallinckrodt Company, Evotec SE, Travere Therapeutics Inc., Aurinia Pharmaceuticals Inc., Orbis Biosciences Inc., Alpine Immune Sciences, Kezar Life Sciences, Zenyaku Kogyo Co. Ltd

Access The Complete Nephrotic Syndrome Market Report:

https://www.thebusinessresearchcompany.com/report/nephrotic-syndrome-global-market-report

Which Regional Market Leads The Nephrotic Syndrome Market?

North America was the largest region in the nephrotic syndrome market in 2025. The regions covered in the nephrotic syndrome market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Nephrotic Syndrome Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=21228&type=smp

Browse Through More Reports Similar to the Global Nephrotic Syndrome Market 2026, By The Business Research Company

Neonatal Infant Care Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/neonatal-infant-care-global-market-report

Acute Respiratory Distress Syndrome Ards Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/acute-respiratory-distress-syndrome-ards-global-market-report

Lower Respiratory Tract Therapeutics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/lower-respiratory-tract-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795